For many of the drugs he prescribes, it takes five to six weeks to know whether they are producing the desired result. "The person with a great outcome and few side effects doesn't happen often enough, so patients and doctors often end up switching to try to get the right drug and that right balance," Dr. Buckley says. "This approach of using genetics to assist in guiding decisions about medications is a very nice advance that has great potential. Any test that can help prevent somebody from getting side effects and even help predict whether a drug might be beneficial for them is a huge issue."
"We are grateful to Drs. Peiper and Wang for their efforts to acquire this technology for MCG and excited about the opportunity to pioneer this emergent technology in clinical psychiatry," says Dr Adriana Foster, an expert in schizophrenia and mood disorders who recently joined the MCG faculty from the University of Baylor. Dr. Foster will help Dr Wang lead the collaborative initiative.
MCG psychiatrists will first use the technology, which has fairly broad applicability to drugs they most often prescribe, in patients who have experienced side effects from drugs or who develop them.